Complete response of age-related Epstein-Barr virus-associated polymorphic nodal lymphoproliferative disease of plasmacytic type to low-dose lenalidomide

Ann Hematol. 2018 Feb;97(2):363-366. doi: 10.1007/s00277-017-3159-7. Epub 2017 Oct 24.

Authors

Yu-Yan Hwang¹, Rex Au-Yeung², Hon-Pang Lau², Yok-Lam Kwong³

Affiliations

¹ Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, Hong Kong.
² Department of Pathology, Queen Mary Hospital, Hong Kong, Hong Kong.
³ Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, Hong Kong. ylkwong@hkucc.hku.hk.

PMID: 29063179
DOI: 10.1007/s00277-017-3159-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Aging / immunology*
Antigens, CD / analysis
Epstein-Barr Virus Infections / complications*
Humans
Immunocompromised Host
Lenalidomide
Lymph Nodes / pathology
Lymphoproliferative Disorders / diagnostic imaging
Lymphoproliferative Disorders / drug therapy*
Lymphoproliferative Disorders / etiology
Lymphoproliferative Disorders / pathology
Male
Plasma Cells / pathology
Positron Emission Tomography Computed Tomography
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Antigens, CD
Thalidomide
Lenalidomide